✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals

Clinitech Laboratory Ltd.

CTLLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹10 Cr.
P/E
25.44

Clinitech Laboratory Ltd.

  • Clinitech Laboratory
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

FAQs on Clinitech Laboratory Ltd. Shareprice

Clinitech Laboratory has given lower returns compared to its competitors.
Clinitech Laboratory has grown at ~-47.49% over the last 1yrs while peers have grown at a median rate of -12.4%

Clinitech Laboratory is not expensive.
Latest PE of Clinitech Laboratory is 25.44, while 3 year average PE is 37.42.
Also latest EV/EBITDA of Clinitech Laboratory is 3.78 while 3yr average is 16.56.

View FAQ's On Business

Growth Table

  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Balance Sheet

  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Cash Flow

  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Quarterly Results

  • Clinitech Laboratory Ltd.
  • DhanvantriJeevan Rek
  • Dr Lalchandani Labs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Clinitech Laboratory Ltd. Financials

Balance sheet of Clinitech Laboratory is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Clinitech Laboratory is decreasing.
Latest net debt of Clinitech Laboratory is -₹5.21 Crs as of Mar-25.
This is less than Mar-24 when it was ₹0.13 Crs.

The profit is oscillating.
The profit of Clinitech Laboratory is ₹0.39 Crs for Mar 2025, ₹0.37 Crs for Mar 2024 and ₹0.61 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Clinitech Laboratory latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech